MC2039A1 - Proteine ayant un ou plusieurs determinants immuno-reactifs et/ou antigeniques d'un antigene de surface d'eimeria,utilisation et procede de preparation - Google Patents

Proteine ayant un ou plusieurs determinants immuno-reactifs et/ou antigeniques d'un antigene de surface d'eimeria,utilisation et procede de preparation

Info

Publication number: MC2039A1
Authority: MC; Monaco
Prior art keywords: immuno; reactive; protein; preparation; surface antigen
Prior art date: 1988-06-03

Application number

MC892053A

Other languages

English (en)

French (fr)

Inventor

Altenburger Werner

Binger Mary-Helen

Anthony Chizzonite Richard

Allen Kramer Richard

Thomas Lomedico Peter

J Mcandrew Stephen

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-06-03

Filing date

1989-06-02

Publication date

1990-05-30

1989-06-02 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1990-05-30 Publication of MC2039A1 publication Critical patent/MC2039A1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/455—Eimeria
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Wood Science & Technology (AREA)
Biophysics (AREA)
General Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Microbiology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Plant Pathology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Physics & Mathematics (AREA)
Animal Behavior & Ethology (AREA)
Toxicology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Gastroenterology & Hepatology (AREA)
Tropical Medicine & Parasitology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

MC892053A 1988-06-03 1989-06-02 Proteine ayant un ou plusieurs determinants immuno-reactifs et/ou antigeniques d'un antigene de surface d'eimeria,utilisation et procede de preparation MC2039A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US20272188A	1988-06-03	1988-06-03

Publications (1)

Publication Number	Publication Date
MC2039A1 true MC2039A1 (fr)	1990-05-30

Family

ID=22750986

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MC892053A MC2039A1 (fr)	1988-06-03	1989-06-02	Proteine ayant un ou plusieurs determinants immuno-reactifs et/ou antigeniques d'un antigene de surface d'eimeria,utilisation et procede de preparation

Country Status (22)

Country	Link
US (2)	US5661015A (xx)
EP (1)	EP0344808B1 (xx)
JP (1)	JP3051130B2 (xx)
KR (1)	KR0156545B1 (xx)
CN (3)	CN1040126C (xx)
AR (1)	AR241942A1 (xx)
AT (1)	ATE120489T1 (xx)
AU (1)	AU635704B2 (xx)
CA (1)	CA1340538C (xx)
DE (1)	DE68921923T2 (xx)
DK (1)	DK272889A (xx)
ES (1)	ES2070866T3 (xx)
FI (1)	FI101453B (xx)
HU (1)	HU212505B (xx)
IE (1)	IE67544B1 (xx)
IL (1)	IL90489A0 (xx)
MC (1)	MC2039A1 (xx)
NO (1)	NO303876B1 (xx)
NZ (1)	NZ229377A (xx)
PT (1)	PT90727B (xx)
YU (1)	YU47880B (xx)
ZA (1)	ZA893740B (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5174993A (en) *	1981-12-24	1992-12-29	Health Research Inc.	Recombinant avipox virus and immunological use thereof
US5279960A (en) *	1984-07-05	1994-01-18	Enzon Corp.	25 KD coccidial antigen of eimeria tenella
US5273901A (en) *	1984-07-05	1993-12-28	Enzon Corp.	Genetically engineered coccidiosis sporozoite 21.5 Kb antigen, ac-6b
US5824656A (en) *	1988-01-15	1998-10-20	Merck & Co., Inc.	Recombinant and native group B eimeria tenella immunogens useful as coccidiosis vaccines
EP0432168B1 (en) *	1988-07-05	1996-10-16	British Technology Group Usa Inc	Genetically engineered coccidiosis vaccine
ZA902147B (en) *	1989-03-28	1990-12-28	Akzo Nv	Coccidiosis vaccine
DE68909041T2 (de) *	1989-06-21	1994-01-13	Akzo Nv	Eimeria tenella-Vakzin.
ZA9010461B (en) *	1990-01-26	1991-10-30	Hoffmann La Roche	Recombinant coccidiosis vaccines-5-7 eimeria surface antigen
CA2106093A1 (en) *	1991-03-14	1992-09-15	David E. Harwood	Recombinant anticoccidial vaccine
US5403581A (en) *	1991-07-12	1995-04-04	Hoffmann-La Roche Inc.	Coccidiosis vaccines
US6008342A (en) *	1991-07-12	1999-12-28	Roche Vitamins Inc.	DNA encoding eimeria antigen
DE69520509T2 (de)	1995-06-07	2001-07-12	Pfizer Inc., New York	In ovo impfung gegen coccidiose
ES2158108T3 (es)	1995-06-07	2001-09-01	Pfizer	Vacunacion in ovo contra la coccidiosis.
DE69635472T2 (de) *	1995-07-03	2006-04-13	Akzo Nobel N.V.	Impfstoff gegen Geflügelkokzidose
EP0921814A4 (en) *	1996-03-29	2001-10-04	Life Technologies Inc	Process for increasing the viability and transformation efficiency of bacteria during storage at low temperatures
US6632923B1 (en)	1996-11-27	2003-10-14	Boston Heart Foundation, Inc.	Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
US6627205B2 (en)	1997-12-01	2003-09-30	Pfizer Incorporated	Ovo vaccination against coccidiosis
US6984378B1 (en)	1999-02-26	2006-01-10	Pfizer, Inc.	Method for the purification, recovery, and sporulation of cysts and oocysts
ZA200400479B (en) *	2001-07-06	2006-05-31	Abic Biolog Lab Teva	Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use
KR100490669B1 (ko) *	2001-08-30	2005-05-19	(주)아비코아생명공학연구소	조류 콕시듐증을 유발하는 에이메리아 종의 포자소체 표면항원에 대한 ｓｃＦｖ 재조합 항체
DE60237977D1 (de)	2001-08-30	2010-11-25	Embrex Inc	Verbesserte verfahren zur herstellung von oozysten
JP3995541B2 (ja) *	2002-06-28	2007-10-24	株式会社ゲン・コーポレーション	抗鶏コクシジウム症組成物
DE10330235A1 (de) *	2003-07-04	2005-01-20	Bayer Healthcare Ag	Neues Eimeria Gen und Protein sowie deren Verwendung
CA2579635A1 (en) *	2003-09-10	2005-03-17	Baxter International Inc.	Peptides that inhibit complement activation
EP1742656B1 (en) *	2004-03-12	2010-06-16	University Of Georgia Research Foundation, Inc.	Novel peanut skin extract as a vaccine adjuvant
US7087425B2 (en) *	2004-03-31	2006-08-08	Embrex, Inc.	Method of purifying oocysts using enzymatic digestion of fecal debris
US20110078828A1 (en) *	2004-09-10	2011-03-31	Guardian Biotechnologies Inc.	Multi epitope vaccine for poultry
EP1666489B1 (en) *	2004-12-01	2007-11-21	Zeon Corporation	DNA encoding an antigenic protein of eimeria apical membrane antigen 1 and use thereof
CN100398156C (zh) *	2005-11-23	2008-07-02	南京农业大学	用于预防鸡球虫病的免疫调节型dna疫苗
US20080194006A1 (en) *	2007-02-08	2008-08-14	Embrex, Inc.	Methods of releasing sporocysts from oocysts using controlled shear forces
US11701683B2 (en)	2010-12-22	2023-07-18	The Procter & Gamble Company	Methods for foil stamping parts having asymmetrical edges
WO2018115229A1 (en)	2016-12-22	2018-06-28	Intervet International B.V.	Eimeria vaccine with improved efficacy
AU2020283954A1 (en) *	2019-05-28	2021-12-16	Case Western Reserve University	Compositions and methods for preserving DNA methylation

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4237224A (en)	1974-11-04	1980-12-02	Board Of Trustees Of The Leland Stanford Jr. University	Process for producing biologically functional molecular chimeras
DE2814039C3 (de)	1978-03-31	1981-02-19	Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig	Verfahren zur Herstellung von Hybrid-Bakterien
EP0135073A3 (en) *	1983-08-19	1987-05-27	American Cyanamid Company	Antigens and monoclonal antibodies reactive against merozites of eimeria spp.
US4650676A (en)	1983-08-19	1987-03-17	American Cyanamid Company	Antigens and monoclonal antibodies reactive against merozoites of Eimeria spp.
EP0135712A3 (en) *	1983-08-19	1987-05-27	American Cyanamid Company	Antigens and monoclonal antibodies reactive against sporozoites of eimeria spp.
US4710377A (en) *	1983-08-19	1987-12-01	American Cyanamid Company	Antigens and monoclonal antibodies reactive against sporozoites of Eimeria spp.
CA1340520C (en) *	1984-06-05	1999-05-04	Karel Z. Newman Jr.	Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by eimeria tenella and eimeria necatrix
US4874705A (en) *	1985-05-16	1989-10-17	Solvay & Cie, S.A.	DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella
US5187080A (en) *	1984-06-05	1993-02-16	Solvay & Cie S.A.	DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella
US4639372A (en)	1984-06-29	1987-01-27	Merck & Co., Inc.	Coccidiosis vaccine
EP0190254A4 (en) *	1984-07-05	1987-03-09	Genex Corp	GENE CLONE AND PROCESS FOR THE PREPARATION AND USE THEREOF.
US5273901A (en) *	1984-07-05	1993-12-28	Enzon Corp.	Genetically engineered coccidiosis sporozoite 21.5 Kb antigen, ac-6b
DE3650540T2 (de) *	1985-12-03	1997-02-27	Solvay	Antigene Proteine und diese enthaltende Impfstoffe zur Verhütung von Kokzidiose
EP0241139A3 (en) *	1986-03-13	1989-04-19	Merck & Co. Inc.	Anti-idiotypic vaccine for coccidiosis
US5496550A (en) *	1986-08-14	1996-03-05	Chilwalner	Method of reducing the output of Eimeria oocysts from a newborn chick
ATE145245T1 (de) *	1987-03-06	1996-11-15	Amgen Boulder Inc	Polypeptide zur verwendung bei der diagnose von kokkidien-infektion und rekombinant-dns, verfahren zur herstellung derselben
EP0315073A2 (en) *	1987-11-02	1989-05-10	Matsushita Electric Industrial Co., Ltd.	A composition for pattern forming materials
NZ227595A (en) *	1988-01-15	1991-11-26	Merck & Co Inc	Recombinant production of eimeria tenella antigens and their use
NZ227597A (en) *	1988-01-15	1991-11-26	Merck & Co Inc	Eimeria tenella group b immunogens and their production
AU620366B2 (en) *	1988-02-12	1992-02-20	United States of America, as represented by the Secretary, U.S. Department of Commerce, The	Cloned genes coding for avian coccidiosis antigens which induce a cell-mediated response and method of producing the same
DE3926461A1 (de) *	1989-07-15	1991-01-24	Suttner Gmbh & Co Kg	Ventilpistole, insbesondere fuer ein hochdruckreinigungsgeraet

1989
- 1989-05-18 ZA ZA893740A patent/ZA893740B/xx unknown
- 1989-06-01 IL IL90489A patent/IL90489A0/xx unknown
- 1989-06-01 NZ NZ229377A patent/NZ229377A/en unknown
- 1989-06-01 AR AR89314066A patent/AR241942A1/es active
- 1989-06-02 ES ES89110056T patent/ES2070866T3/es not_active Expired - Lifetime
- 1989-06-02 NO NO892251A patent/NO303876B1/no not_active IP Right Cessation
- 1989-06-02 YU YU113889A patent/YU47880B/sh unknown
- 1989-06-02 MC MC892053A patent/MC2039A1/xx unknown
- 1989-06-02 AT AT89110056T patent/ATE120489T1/de not_active IP Right Cessation
- 1989-06-02 HU HU892814A patent/HU212505B/hu not_active IP Right Cessation
- 1989-06-02 AU AU36016/89A patent/AU635704B2/en not_active Ceased
- 1989-06-02 PT PT90727A patent/PT90727B/pt not_active IP Right Cessation
- 1989-06-02 DK DK272889A patent/DK272889A/da not_active Application Discontinuation
- 1989-06-02 DE DE68921923T patent/DE68921923T2/de not_active Expired - Fee Related
- 1989-06-02 CA CA000601631A patent/CA1340538C/en not_active Expired - Fee Related
- 1989-06-02 FI FI892714A patent/FI101453B/fi not_active IP Right Cessation
- 1989-06-02 EP EP89110056A patent/EP0344808B1/en not_active Expired - Lifetime
- 1989-06-03 JP JP1140268A patent/JP3051130B2/ja not_active Expired - Lifetime
- 1989-06-03 KR KR1019890007661A patent/KR0156545B1/ko not_active IP Right Cessation
- 1989-06-03 CN CN89104278A patent/CN1040126C/zh not_active Expired - Fee Related
- 1989-06-12 IE IE181289A patent/IE67544B1/en not_active IP Right Cessation
1991
- 1991-12-20 US US07/812,349 patent/US5661015A/en not_active Expired - Lifetime
1997
- 1997-09-22 CN CN97119228A patent/CN1076204C/zh not_active Expired - Fee Related
- 1997-09-22 CN CN97118698A patent/CN1077438C/zh not_active Expired - Fee Related
2002
- 2002-10-09 US US10/267,430 patent/US20030175311A1/en not_active Abandoned

Also Published As

Publication number	Publication date
FI101453B1 (fi)	1998-06-30
CN1186695A (zh)	1998-07-08
DE68921923T2 (de)	1995-08-10
CN1038837A (zh)	1990-01-17
CN1040126C (zh)	1998-10-07
HU212505B (en)	1996-07-29
FI892714A (fi)	1989-12-04
EP0344808B1 (en)	1995-03-29
CN1076204C (zh)	2001-12-19
AU3601689A (en)	1989-12-07
DK272889A (da)	1989-12-04
YU113889A (en)	1991-10-31
IE891812L (en)	1989-12-03
IL90489A0 (en)	1990-01-18
KR910000183A (ko)	1991-01-29
IE67544B1 (en)	1996-04-17
NZ229377A (en)	1992-06-25
AR241942A1 (es)	1993-01-29
CN1187368A (zh)	1998-07-15
ZA893740B (en)	1990-02-28
US5661015A (en)	1997-08-26
CA1340538C (en)	1999-05-11
PT90727A (pt)	1989-12-29
JP3051130B2 (ja)	2000-06-12
AU635704B2 (en)	1993-04-01
HUT52963A (en)	1990-09-28
JPH037594A (ja)	1991-01-14
PT90727B (pt)	1994-11-30
CN1077438C (zh)	2002-01-09
FI101453B (fi)	1998-06-30
EP0344808A1 (en)	1989-12-06
YU47880B (sh)	1996-05-20
NO892251L (no)	1989-12-04
ATE120489T1 (de)	1995-04-15
KR0156545B1 (ko)	1998-11-16
NO892251D0 (no)	1989-06-02
DK272889D0 (da)	1989-06-02
US20030175311A1 (en)	2003-09-18
DE68921923D1 (de)	1995-05-04
FI892714A0 (fi)	1989-06-02
NO303876B1 (no)	1998-09-14
ES2070866T3 (es)	1995-06-16

Publication	Publication Date	Title
MC2039A1 (fr)	1990-05-30	Proteine ayant un ou plusieurs determinants immuno-reactifs et/ou antigeniques d'un antigene de surface d'eimeria,utilisation et procede de preparation
IT8622842A0 (it)	1986-12-23	Metodo e dispositivo per verificare l'identita' di un individuo.
EP0214282A4 (en)	1989-06-13	PROTIDE ANTIGENS HAVING DEPENDENT AND INDEPENDENT DETERMINANTS OF CONFORMATION.
PT90312A (pt)	1989-11-10	Processo para a preparacao de novos anticorpos recombinantes e quimericos dirigidos contra um antigenio de adenocarcinoma humano
KR900700607A (ko)	1990-08-16	면역학적 주효체 세포 활성화 및 화학적 인력을 유발하는 단백질
IT1232170B (it)	1992-01-25	Emulsione multipla, in particolare di emoglobina, e procedimento per la sua preparazione
IT8622630A0 (it)	1986-12-10	Anticorpi monoclonali crossreattivi e cross-protettivi contro sierotipi di p. aeruginosa.
PT87688A (pt)	1988-07-01	Hybrid protein c and method for its preparation
ES2002467A6 (es)	1988-08-16	Procedimiento para la preparacion de un antigeno peptido inmunogenico correspondiente a la proteina circumsporozoito de plasmodium vivax
KR860004915A (ko)	1986-07-16	아미노아실라브단 및 이의 제조방법
EP0131627A4 (en)	1987-02-26	SPECIFIC ANTIGENS OF THE CEA FAMILY (CARCINO-EMBRYONIC ANTIGEN), SPECIFIC ANTIBODIES OF THESE ANTIGENS AND THEIR METHODS OF USE.
NO180181C (no)	1997-03-05	Fremgangsmåte for fremstilling av et is-kjernedannende protein, plasmider og bakteriestammer
IL108419A0 (en)	1994-04-12	Proteinaceous extract derived from eimeria maxima gametocytes and vaccines against eimeria maxima containing the same
ES2068817T3 (es)	1995-05-01	Procedimiento inmunologico de identificacion para herbicidas.
DE68914252D1 (de)	1994-05-05	Verfahren zur Bestimmung eines Antigens.
ZA879621B (en)	1988-06-17	Method for the determination of anti-p.falciparum sporozoite antibodies in human blood
AU6257486A (en)	1988-03-17	Specific mycoplasma membrane antigen and antibody and their clinical applications
JPS56166465A (en)	1981-12-21	Method of detecting blood typing antigen in tissue piece and product obtained thereby
EP0218587A4 (en)	1988-06-27	MONOCLONAL ANTIBODIES AND IMMUNIZATION METHOD USING THE SAME.
DE68907377D1 (de)	1993-08-05	Agens und geraet zur bestimmung von antigenen oder antikoerpern.
KR870004977A (ko)	1987-06-02	2,2'-바이-1h-이미다졸 및 그의 제조방법
IL81920A (en)	1991-12-12	Vaccines comprising an antigen and interferon-ypsilon and their preparation
BG92796A (bg)	1993-12-24	Метод за откриване на антитела в кръвта,мембранна лента и мембранна батерия за провеждана на метода
DE3850750D1 (de)	1994-08-25	Verfahren zur Verhütung von GVHD.
IL64878A (en)	1986-01-31	Method for detection of and determination of malaria antibodies and malaria antigens in human blood

Legal Events

Date	Code	Title	Description
1992-05-27	YP	Annual fee paid